biological drug


Also found in: Dictionary.

biological drug

n.
References in periodicals archive ?
We need to do more, think differently, think outside the box" of relying primarily on disease-modifying antirheumatic drugs, especially biological drugs, to resolve symptoms in PsA patients.
CEO Eduardo Bravo Cx611 could offer rheumatoid arthritis patients a therapy with an alternative mechanism of action that delays the need to progress to biological drugs.
Wang and Singh, who work in the pharmaceutical industry, assemble 22 chapters that lead pharmaceutical scientists and students through the process of biological drug development and its challenges and strategies.
Biological drugs can be monoclonal antibodies or proteins produced by living cells that bind with receptors on various cells to block formation or action of various cytokines or cell mediators, or in other ways change cell function.
Mycoplasma contamination represents a significant issue during biological drug production," said Ruedi Stoffel of Roche.
The takeover is expected to boost Sigma-Aldrich's activities in the expanding biological drug market, CEO Rakesh Sachdev said.
Islamabad, December 15, 2010 (Frontier Star): A biological drug recently launched in the country has raised serious concerns about the bogus registration procedure of such medicines by the concerned officials of the Ministry of Health.
ISLAMABAD, December 15, 2010 (Balochistan Times): A biological drug recently launched in the country has raised serious concerns about the bogus registration procedure of such medicines by the concerned officials of the Ministry of Health.
exemplifies the trend of pharmaceutical companies purchasing biological drug makers as a way to beef up their pipelines.
With biologics set to be the first, second and third bestselling pharmaceuticals of 2012, the competition for the biologics market is intense, and the coming of biosimilars is going to make it fiercer, by lowering the entry barriers for developing a biological drug.
Such exposure in the supply chain can produce deleterious results with regard to the quality of therapies, particularly among biological drug products.

Full browser ?